These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38340198)
1. A Validation Study of CD133 as a Reliable Marker for Identification of Colorectal Cancer Stem-Like Cells. You CZ; Xu H; Zhao FS; Dou J Bull Exp Biol Med; 2024 Jan; 176(3):369-375. PubMed ID: 38340198 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640 [TBL] [Abstract][Full Text] [Related]
3. Targeting cancer stem cells with an 131I-labeled anti-AC133 monoclonal antibody in human colorectal cancer xenografts. Lang J; Lan X; Liu Y; Jin X; Wu T; Sun X; Wen Q; An R Nucl Med Biol; 2015 May; 42(5):505-512. PubMed ID: 25669587 [TBL] [Abstract][Full Text] [Related]
4. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line. Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445 [TBL] [Abstract][Full Text] [Related]
5. Effects of metformin on CD133+ colorectal cancer cells in diabetic patients. Zhang Y; Guan M; Zheng Z; Zhang Q; Gao F; Xue Y PLoS One; 2013; 8(11):e81264. PubMed ID: 24278407 [TBL] [Abstract][Full Text] [Related]
7. CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116. Dittfeld C; Dietrich A; Peickert S; Hering S; Baumann M; Grade M; Ried T; Kunz-Schughart LA Radiother Oncol; 2009 Sep; 92(3):353-61. PubMed ID: 19699546 [TBL] [Abstract][Full Text] [Related]
8. Microenvironmentally-driven Plasticity of CD44 isoform expression determines Engraftment and Stem-like Phenotype in CRC cell lines. Dinger TF; Chen O; Dittfeld C; Hetze L; Hüther M; Wondrak M; Löck S; Eicheler W; Breier G; Kunz-Schughart LA Theranostics; 2020; 10(17):7599-7621. PubMed ID: 32685007 [TBL] [Abstract][Full Text] [Related]
9. In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines. Zito G; Richiusa P; Bommarito A; Carissimi E; Russo L; Coppola A; Zerilli M; Rodolico V; Criscimanna A; Amato M; Pizzolanti G; Galluzzo A; Giordano C PLoS One; 2008; 3(10):e3544. PubMed ID: 18958156 [TBL] [Abstract][Full Text] [Related]
10. The most reliable surface marker for the identification of colorectal cancer stem-like cells: A systematic review and meta-analysis. Abbasian M; Mousavi E; Arab-Bafrani Z; Sahebkar A J Cell Physiol; 2019 Jun; 234(6):8192-8202. PubMed ID: 30317669 [TBL] [Abstract][Full Text] [Related]
11. A possible interplay between HR-HPV and stemness in tumor development: an in vivo investigation of CD133 as a putative marker of cancer stem cell in HPV18-infected KB cell line. de Maria S; Santoro A; Fuggetta MP; Rocchetti R; Cottarelli A; Lanzilli G; Stiuso P; Angelico G; Spadola S; Franco Zannoni G; Rubini C; Emanuelli M; Carmela Pedicillo M; Pannone G; Muzio LL APMIS; 2020 Dec; 128(12):637-646. PubMed ID: 32911563 [TBL] [Abstract][Full Text] [Related]
12. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways. Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944 [TBL] [Abstract][Full Text] [Related]
13. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines. Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of microRna-200c in CD44+CD133+ CSCS inhibits the cellular migratory and invasion as well as tumorigenicity in mice. Dou J; He XF; Cao WH; Zhao FS; Wang XY; Liu YR; Wang J Cell Mol Biol (Noisy-le-grand); 2013 Oct; Suppl 59():OL1861-8. PubMed ID: 24120113 [TBL] [Abstract][Full Text] [Related]
15. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells. Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042 [TBL] [Abstract][Full Text] [Related]
16. Biological significance of tumor budding at the invasive front of human colorectal carcinoma cells. Yusra ; Semba S; Yokozaki H Int J Oncol; 2012 Jul; 41(1):201-10. PubMed ID: 22569829 [TBL] [Abstract][Full Text] [Related]
17. Knocking down LSD1 inhibits the stemness features of colorectal cancer stem cells. Chen J; Zhao J; Ding J; Wang Z; Du J; Wu C Braz J Med Biol Res; 2020; 53(7):e9230. PubMed ID: 32520208 [TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice. Wang D; Fu L; Sun H; Guo L; DuBois RN Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008 [TBL] [Abstract][Full Text] [Related]
19. Autophagy promotes resistance to photodynamic therapy-induced apoptosis selectively in colorectal cancer stem-like cells. Wei MF; Chen MW; Chen KC; Lou PJ; Lin SY; Hung SC; Hsiao M; Yao CJ; Shieh MJ Autophagy; 2014 Jul; 10(7):1179-92. PubMed ID: 24905352 [TBL] [Abstract][Full Text] [Related]
20. CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity. Shi CJ; Gao J; Wang M; Wang X; Tian R; Zhu F; Shen M; Qin RY World J Gastroenterol; 2011 Jun; 17(24):2965-71. PubMed ID: 21734809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]